New insider activity at Aurinia Pharmaceuticals ( (AUPH) ) has taken place on March 8, 2025.
CMO Greg Keenan recently sold 8,305 shares of Aurinia Pharmaceuticals stock, amounting to a total transaction value of $68,350.
More about Aurinia Pharmaceuticals
YTD Price Performance: -6.61%
Average Trading Volume: 1,472,238
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.19B